Fundraising Fox

Maculaser

Helsinki, FI · 2 known investors

maculaser.com ↗

Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

JTJani Tirronen
Jani TirronenCEO
TTTeemu Turunen
Teemu TurunenChief Scientific Officer, PhD
OKOssi Kaikkonen
Ossi KaikkonenHead of Product
JNJaakko Nieminen
Jaakko NieminenCTO, PhD
AVAki Vartiainen
Aki VartiainenClinical Trial Manager

Investors · 2

Innovestor VenturesHelsinki · $270K – $3.2M
ZEISS VenturesreportedOberkochen

In the news

Zeiss Backs Maculaser to Fund Retinal Laser Therapy | VMvisionmonday.com · Jun 2026M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy - M2CAREm2.care · May 2026Health Incubator Helsinki companies Maculaser, Finnadvance and Sartar Therapeutics secured new funding - Health Incubator Helsinkihealthincubatorhelsinki.com · Sep 2021Maculaser raised €1.2 million in funding to combat blindness | Global Health Connectorglobalhealthconnector.com · Feb 2021Innovestor invests in Maculaser - Developing new laser therapy combating blinding diseases - Innovestorinnovestorgroup.com · Feb 2021

Frequently asked questions

What does Maculaser do?
Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.
Who are Maculaser's investors?
Maculaser's investors include Innovestor Ventures, ZEISS Ventures.
Where is Maculaser headquartered?
Maculaser is headquartered in Helsinki, FI.